Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
30/12/2025 22:24
Dec 30 (Reuters) - Neoimmunetech Inc 950220.KQ: EMMAUS LIFE SCIENCES INC - ENTERS LICENSE AND DISTRIBUTION AGREEMENT WITH NEOIMMUNETECH EMMAUS LIFE SCIENCES INC - GRANTS NIT EXCLUSIVE LICENSE TO MARKET, SELL AND DISTRIBUTE ENDARI IN U.S. AND CANADA EMMAUS LIFE SCIENCES INC - AGREEMENT INCLUDES UPFRONT PAYMENT AND ROYALTY ON NIT'S SALES Source text: ID:nBw3c9Wrza Further company coverage: 950220.KQ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns